Cargando…
The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas
Human pituitary adenomas are one of the most common intracranial neoplasms. Although most of these tumors are benign and can be treated medically or by transsphenoidal surgery, a subset of these tumors are fast-growing, aggressive, recur, and remain a therapeutic dilemma. Because antibodies against...
Autores principales: | Xi, Zhiyu, Jones, Pamela S., Mikamoto, Masaaki, Jiang, Xiaobin, Faje, Alexander T., Nie, Chuansheng, Labelle, Kathryn E., Zhou, Yunli, Miller, Karen K., Soberman, Roy J., Zhang, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566912/ https://www.ncbi.nlm.nih.gov/pubmed/34745002 http://dx.doi.org/10.3389/fendo.2021.726448 |
Ejemplares similares
-
Sprouting Angiogenesis in Human Pituitary Adenomas
por: Zhou, Jie, et al.
Publicado: (2022) -
The Epigenomics of Pituitary Adenoma
por: Hauser, Blake M., et al.
Publicado: (2019) -
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020) -
Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018) -
The Treatment of Refractory Pituitary Adenomas
por: Dai, Congxin, et al.
Publicado: (2019)